Ebola drug by next year
Print Edition
CLINICAL trials of a preventative vaccine for the Ebola virus made by British pharmaceutical giant GlaxoSmithKline might begin next month, with the drug possibly available next year, the World Health Organization said yesterday.
“We’re targeting September for the start of clinical trials, first in the US and certainly in African countries, since that’s where we have the cases,” Jean-Marie Okwo Bele, the WHO’s head of vaccines, said.
He said he was optimistic about making the vaccine commercially available.
“We think if we start in September, we could already have results by the end of the year.
“And as this is an emergency, we can put emergency procedures in place ... so we can have a vaccine available by 2015.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
